These included previously described mutational oncogenes NFE2L2 in esophagus carcinoma, BRAF and NRAS in melanoma and CTNNB1 in non-small cell lung cancer, all of which have been reported in IntOGen (9) as mutational drivers in their respective cancer types. This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.